RSV Strains Are Evolving Faster Than Expected, But Vaccines Aren't Driving It,Yet
New genomic analysis of RSV in Georgia reveals diverse virus variants circulating in 2024-2025, with only 18% vaccine uptake among eligible adults.
51 articles
New genomic analysis of RSV in Georgia reveals diverse virus variants circulating in 2024-2025, with only 18% vaccine uptake among eligible adults.
Measles cases among adults have surged in 2025 and 2026, posing serious risks to pregnant women including miscarriage, preterm birth, and severe newborn...
A new H5N1 bird flu genotype called D1.1 spread rapidly across North America during fall 2024, displacing earlier variants.
A major study across South and Southeast Asia found that new diagnostic tools can identify 89% of children at risk of life-threatening sepsis, compared to just...
Drug-resistant infections cause nearly 3 million illnesses and 35,000 deaths annually in the US.
Australia launched a groundbreaking RSV prevention program in 2025, offering free vaccines to pregnant women and monoclonal antibodies to infants.
Researchers at Fred Hutch developed a blood-testing method that measures how well human antibodies fight multiple flu strains simultaneously, helping the WHO...
The First Nations Health Authority released an evidence brief to advance healthcare accessibility for Indigenous communities in British Columbia, addressing...
A large German study found that seasonal COVID-19 vaccines reduced long COVID cases by 57% and lowered overall mortality by 25%, with significant healthcare...
Tuberculosis cases in the US reached their highest level since 2013, with over 10,300 confirmed cases in 2024.
A comparative immunologist reveals how studying immune systems across species, from fish to pigs, is revealing universal principles that could transform...
China reported 22 H9N2 avian flu cases in six months, nearly doubling 2024's total.
A major study shows HPV vaccines cut cancer risk in men by nearly 50%, preventing head, neck, and other cancers beyond cervical disease.
The CDC has paused testing for rabies and monkeypox, shifting responsibility to state labs.
South Carolina's measles outbreak has stalled at 997 cases with no new infections reported since mid-March.
The Global Research on Antimicrobial Resistance Project is hosting free webinars to help policymakers translate AMR data into actionable interventions, with...
A breakthrough urine test identifies the right antibiotic for UTIs in under six hours instead of days, potentially transforming how doctors treat one of the...
The CDC monitors nine lesser-known respiratory pathogens that cause thousands of infections yearly. Here's what you need to know about these overlooked threats.
Flu, COVID, and RSV are still spreading in spring 2026 with nearly identical symptoms. Here's how to know which one you have.
Human metapneumovirus hospitalizations cost nearly $20,000 per patient, matching RSV expenses.
NanoViricides begins Phase II trials of NV-387, a broad-spectrum antiviral designed to treat monkeypox when existing drugs have failed.
Measles cases in the U.S. have reached 1,575 in 2026, continuing a troubling trend from 2025, the worst year since 1991.
As social media algorithms amplify conflicting health messages, journalists and public health experts face an uphill battle communicating nuanced science.
Current flu vaccines are only 30% effective against hospitalizations in adults, prompting health officials to fast-track next-generation shots that could...
A veteran physician warns that erosion of vaccine confidence among healthcare providers threatens decades of disease prevention progress.
Researchers at Trinity College Dublin found a way to boost immune cells called macrophages to better kill drug-resistant bacteria like TB and MRSA, offering...
Vermont's wastewater monitoring system detects flu and COVID viruses before people show symptoms, giving communities an early warning to boost precautions.
Antibiotic resistance is reshaping how pneumonia, MRSA, and gonorrhea spread and worsen.
A new COVID-19 variant with 75 mutations has been detected in 25 U.S. states, though current levels remain low at 0.19% of samples.
Scientists discovered that a yellow fever-based vaccine protects against Sudan virus by activating immune cells rather than antibodies, offering hope for...
Europe is missing 1 in 5 tuberculosis cases, creating a dangerous cycle where undiagnosed patients spread drug-resistant strains.
New research shows the 2025-2026 flu vaccine generates protective antibodies against the rapidly spreading H3N2 subclade K variant in 39% of vaccinated people,...
A Canadian study of 6.4 million people found vaccinated young adults were 43% less likely to experience sudden death than unvaccinated peers, debunking...
Tuberculosis cases in the U.S. jumped 7.9% in 2024, yet 17 promising vaccine candidates are in development. Here's why experts say innovation offers real hope.
A new study finds only 51% of hospital staff wear masks in most settings, even though vaccination rates are high. Here's what's driving the disconnect.
A federal advisory committee's report on post-vaccine symptoms relied on unvalidated tests and a 300-fold uncertainty in prevalence estimates, raising concerns...
Nursing programs are redesigning microbiology courses to teach the 'One Health' framework, which connects human health to animal and environmental factors.
66 health organizations are urging Congress to fund NIAID at $7.15 billion for 2027, citing breakthroughs in RSV vaccines, antibiotic resistance, and food...
A new survey reveals Americans have more confidence in career scientists at federal health agencies than in agency leaders, even as trust in public health...
New research shows severe COVID-19 or flu infections can increase lung cancer risk months or years later by altering immune cells, but vaccination appears to...
Vancomycin still treats over 50% of pediatric MRSA cases, but hospitals are increasingly turning to newer antibiotics like ceftaroline.
The FDA expanded RSV vaccine access to adults aged 18-49 with chronic conditions. Younger adults face 17,000 hospitalizations yearly from RSV; here's why this...
New research reveals fire-footed rope squirrels may be the hidden animal source of mpox outbreaks in West Africa, raising concerns about future global spread...
Antibiotic resistance kills 4.95 million people annually and now features in the world's first pandemic agreement.
Multiple respiratory viruses are circulating in New York right now, and they're not COVID or flu.
Mpox cases are spiking in suburban Chicago, but the virus spreads differently than COVID.
Northern Ireland launches 'This Is Our Health,' a public engagement program reshaping how people interact with healthcare.
H5N1 bird flu has infected 11.54 million birds across 67 flocks in just 30 days, with one facility losing 3.2 million egg-laying hens.
A major independent review of the Tdap vaccine in pregnancy is underway amid vaccine skepticism.
Rapid RSV tests cut antibiotic prescriptions in children by nearly half, helping fight antibiotic resistance while improving care accuracy in doctor's offices.